Individualized Adaptive Stereotactic Body Radiotherapy for Liver Tumors

This phase 2 clinical trial evaluated the safety and efficacy of individualized adaptive stereotactic body radiotherapy for liver tumors in patients who have preexisting liver dysfunction.

http://ift.tt/2vSFZ6M